ロード中...
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
Rivaroxaban is a direct factor Xa inhibitor that is widely available to reduce the risk of stroke or systemic embolism in patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. Rivaroxaban provides practical advantages compared with warfarin and other vitamin K antago...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3956810/ https://ncbi.nlm.nih.gov/pubmed/24648742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S55246 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|